Article
De novo masking domains that gate TNF-family ligand assembly and activity
2026-04-22
Abstract excerpt
Tumor necrosis factor family ligands (TNFLs) are central regulators of immunity and promising agents for cancer therapy, but their clinical use is often limited by dose-limiting systemic toxicity. Conditional activation and genetic fusion with antibodies could improve safety and pharmacokinetics, yet these features are difficult to combine because TNFLs form obligate homotrimers that are structurally mismatched wi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6df67731-c41c-51cb-adcf-111dd986b31c
- DOI
- 10.64898/2026.04.20.719557
